Ultrasensitive liquid biopsy affective in predicting and monitoring immunotherapy response, study shows

byVall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPublishedtoday inClinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of O

Updated on: April 05,2026

Ultrasensitive liquid biopsy affective in predicting and monitoring immunotherapy response, study shows

byVall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPublishedtoday inClinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of O

Updated on:April 05,2026

Differences persist in cancer mortality burden by where patients live, socioeconomic status, race/ethnicity

byAmerican Cancer SocietySocial determinants of health and cancer disparities. Credit:CA: A Cancer Journal for Clinicians(2025). DOI: 10.3322/caac.70045In new research on the status of cancer disparit

Updated on: February 14,2026

Differences persist in cancer mortality burden by where patients live, socioeconomic status, race/ethnicity

byAmerican Cancer SocietySocial determinants of health and cancer disparities. Credit:CA: A Cancer Journal for Clinicians(2025). DOI: 10.3322/caac.70045In new research on the status of cancer disparit

Updated on:February 14,2026

Doctors say lung cancer is still the deadliest cancer, but hope is growing

by I. EdwardsLung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in screening, surgery and personalized treatment are helping more patie

Updated on: February 19,2026

Doctors say lung cancer is still the deadliest cancer, but hope is growing

by I. EdwardsLung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in screening, surgery and personalized treatment are helping more patie

Updated on:February 19,2026

Latin American research indicates a lower prevalence of a type of head and neck cancer

by Maria Fernanda Ziegler,FAPESPCredit: Picas Joe from PexelsSquamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth-most common c

Updated on: March 08,2026

Latin American research indicates a lower prevalence of a type of head and neck cancer

by Maria Fernanda Ziegler,FAPESPCredit: Picas Joe from PexelsSquamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth-most common c

Updated on:March 08,2026

Newly identified lymphoma subtype gives hope in fight against aggressive form of blood cancer

byUniversity of SouthamptonCredit: Unsplash/CC0 Public DomainResearchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targete

Updated on: March 22,2026

Newly identified lymphoma subtype gives hope in fight against aggressive form of blood cancer

byUniversity of SouthamptonCredit: Unsplash/CC0 Public DomainResearchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targete

Updated on:March 22,2026

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

byUniversity of California - San DiegoCredit: Unsplash/CC0 Public DomainA new University of California San Diegostudyoffers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists—t

Updated on: February 25,2026

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

byUniversity of California - San DiegoCredit: Unsplash/CC0 Public DomainA new University of California San Diegostudyoffers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists—t

Updated on:February 25,2026

Macrophage 'bodyguard' disruptors may help overcome hormone-resistant breast cancer

byUniversity of Miami Leonard M. Miller School of Medicine"This triple therapy approach could be a game-changer for patients whose (breast) cancers no longer respond to standard hormone treatment

Updated on: March 14,2026

Macrophage 'bodyguard' disruptors may help overcome hormone-resistant breast cancer

byUniversity of Miami Leonard M. Miller School of Medicine"This triple therapy approach could be a game-changer for patients whose (breast) cancers no longer respond to standard hormone treatment

Updated on:March 14,2026

How to reduce risk of lymphedema after head and neck cancer

by Åsa Hansdotter,Lund UniversityCredit:Oral Oncology(2025). DOI: 10.1016/j.oraloncology.2025.107671Lymphedema after head and neck cancer is considerably more common than previously assumed and can pe

Updated on: March 07,2026

How to reduce risk of lymphedema after head and neck cancer

by Åsa Hansdotter,Lund UniversityCredit:Oral Oncology(2025). DOI: 10.1016/j.oraloncology.2025.107671Lymphedema after head and neck cancer is considerably more common than previously assumed and can pe

Updated on:March 07,2026

FDA grants fast track designation to drug combo for colorectal cancer

by April Wilkerson,University of OklahomaCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal c

Updated on: February 20,2026

FDA grants fast track designation to drug combo for colorectal cancer

by April Wilkerson,University of OklahomaCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal c

Updated on:February 20,2026

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Schematic representation of 3-step HER2-targeted225Ac-PRIT,225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenog

Updated on: March 04,2026

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Schematic representation of 3-step HER2-targeted225Ac-PRIT,225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenog

Updated on:March 04,2026

Nanovaccine shows great promise for treating HPV-related cancers

byUTSouthwestern Medical CenterSTING nanovaccine is designed to deliver tumor antigens (Ag) and STING agonists (diABZI, PSC7A) to the tumor and secondary lymphoid organs (SLOs) to activate antit

Updated on: March 17,2026

Nanovaccine shows great promise for treating HPV-related cancers

byUTSouthwestern Medical CenterSTING nanovaccine is designed to deliver tumor antigens (Ag) and STING agonists (diABZI, PSC7A) to the tumor and secondary lymphoid organs (SLOs) to activate antit

Updated on:March 17,2026

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

by Lori SolomonLong-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a studypublishedonline Oct. 10 inSLEEPJ.Michael R. Irwin

Updated on: February 14,2026

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

by Lori SolomonLong-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a studypublishedonline Oct. 10 inSLEEPJ.Michael R. Irwin

Updated on:February 14,2026